Recent studies have discovered a role for the transporter protein xCT in the survival of different cancer cell types including breast, glioma and lymphoma.
Congratulations to a Vanderbilt research collaborator on receiving Medicare approval of a diagnostic test for patients with advanced non-small cell lung cancer (NSCLC).
